Search





Search





Markets
/
Stocks
/
lyel
/

Lyell Immunopharma Inc

LYEL

Add to Watchlist

12.750USD

-0.090-0.70%

Close 07-23 16:00（ET）Quotes delayed by 15 min

297.43MMarket Cap

LossP/E TTM

Lyell Immunopharma Inc

12.750

-0.090-0.70%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

LYEL Income Statement

You can find the annual or quarterly income statement of Lyell Immunopharma Inc here for insights into the performance and operational efficiency of Lyell Immunopharma Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

-71.43%2.00K

-45.45%6.00K

-55.88%15.00K

-38.46%8.00K

133.33%7.00K

-15.38%11.00K

36.00%34.00K

-51.85%13.00K

-95.38%3.00K

-99.97%13.00K

733.33%25.00K

-99.92%27.00K

-88.25%65.00K

1614.60%48.39M

-99.89%3.00K

1260.01%35.74M

-77.38%553.00K

22.06%2.82M

157.48%2.75M

-15.72%2.63M

94.67%2.44M

--2.31M

--1.07M

--3.12M

--1.26M

Revenue

-71.43%2.00K

-45.45%6.00K

-55.88%15.00K

-38.46%8.00K

133.33%7.00K

-15.38%11.00K

36.00%34.00K

-51.85%13.00K

-95.38%3.00K

-99.97%13.00K

733.33%25.00K

-99.92%27.00K

-88.25%65.00K

1614.60%48.39M

-99.89%3.00K

1260.01%35.74M

-77.38%553.00K

22.06%2.82M

157.48%2.75M

-15.72%2.63M

94.67%2.44M

--2.31M

--1.07M

--3.12M

--1.26M

Operating expenses

-23.02%44.26M

-2.94%61.32M

-28.02%37.27M

-15.67%44.76M

5.29%57.50M

1.40%63.17M

-12.34%51.77M

-19.50%53.08M

-15.11%54.61M

-11.60%62.30M

-7.71%59.06M

-5.02%65.93M

-11.85%64.33M

39.95%70.48M

23.27%64.00M

6.24%69.42M

26.23%72.98M

20.37%50.36M

36.93%51.92M

-38.18%65.33M

68.75%57.81M

--41.84M

--37.91M

--105.68M

--34.26M

R&D expenses

-15.99%36.60M

6.17%52.20M

-30.84%28.17M

-16.33%34.97M

3.24%43.57M

-1.23%49.16M

-7.10%40.73M

-11.95%41.80M

-8.92%42.21M

9.78%49.77M

11.96%43.85M

18.29%47.47M

16.78%46.34M

135.10%45.34M

24.60%39.17M

-13.59%40.13M

-4.45%39.68M

-45.04%19.29M

28.29%31.43M

-52.19%46.45M

62.86%41.53M

--35.09M

--24.50M

--97.15M

--25.50M

Depreciation, depletion, and amortization

-32.23%2.33M

-52.31%2.40M

-45.17%2.57M

-36.03%3.13M

-31.51%3.44M

-0.61%5.03M

-8.31%4.68M

-3.18%4.90M

-0.06%5.02M

0.32%5.06M

10.45%5.10M

21.36%5.06M

20.06%5.03M

10.43%5.04M

12.96%4.62M

38.57%4.17M

113.84%4.19M

214.39%4.56M

270.56%4.09M

212.89%3.01M

152.32%1.96M

--1.45M

--1.10M

--962.00K

--776.00K

Other operating expenses

-1493.28%-1.90M

-191.81%-1.50M

-117.95%-1.59M

----

89.08%-119.00K

19.97%-513.00K

-150.00%-730.00K

-71.53%-976.00K

15.37%-1.09M

47.02%-641.00K

76.66%-292.00K

51.41%-569.00K

-14.80%-1.29M

-51.63%-1.21M

-65.04%-1.25M

-425.11%-1.17M

-105.87%-1.12M

90.18%-798.00K

-379.75%-758.00K

78.35%-223.00K

-354.17%-545.00K

---8.12M

---158.00K

---1.03M

---120.00K

Operating profit

23.01%-44.26M

2.93%-61.31M

28.00%-37.25M

15.67%-44.75M

-5.28%-57.49M

-1.40%-63.16M

12.36%-51.74M

19.48%-53.06M

15.03%-54.61M

-181.96%-62.29M

7.75%-59.04M

-95.71%-65.91M

11.27%-64.26M

53.53%-22.09M

-30.18%-64.00M

46.30%-33.67M

-30.81%-72.43M

-20.28%-47.54M

-33.43%-49.16M

38.86%-62.71M

-67.77%-55.37M

---39.52M

---36.84M

---102.57M

---33.00M

Net non-operating interest income (expenses)

Non-operating interest income

-43.19%2.19M

-45.61%2.68M

-45.25%3.27M

-48.52%3.28M

-43.36%3.86M

-30.55%4.92M

-9.73%5.96M

20.90%6.36M

51.63%6.82M

105.15%7.08M

193.56%6.61M

452.94%5.26M

1032.75%4.50M

969.04%3.45M

733.70%2.25M

336.70%952.00K

12.15%397.00K

-47.99%323.00K

-75.36%270.00K

-88.41%218.00K

-84.88%354.00K

--621.00K

--1.10M

--1.88M

--2.34M

Special income (expenses)

14231.20%17.91M

40.50%-82.10M

-493.44%-4.86M

-186.46%-1.33M

100.89%125.00K

-5063.49%-137.99M

--1.23M

152.55%1.54M

-68.46%-13.97M

-61.95%2.78M

100.00%0.00

18.83%-2.92M

-313.77%-8.29M

120.05%7.31M

---8.52M

---3.60M

--3.88M

---36.45M

----

Other non-operating income (expenses)

1267.48%17.91M

-99.74%11.00K

----

118.29%118.00K

20.18%1.31M

948.22%4.29M

-102.72%-43.00K

-97.85%-645.00K

-0.91%1.09M

-117.25%-506.00K

12038.46%1.58M

---326.00K

15614.29%1.10M

6768.18%2.93M

-18.75%13.00K

----

125.93%7.00K

-195.65%-44.00K

-42.86%16.00K

-465.52%-106.00K

-101.90%-27.00K

--46.00K

--28.00K

--29.00K

--1.42M

Income before tax

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

Income tax

----

--0.00

----

Income after tax

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

Net income from continuous operations

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

Net income attributable to controlling interests

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

Net income attributable to common shareholders

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

Basic earnings per share

68.79%-1.10

-900.46%-6.86

-1122.52%-2.13

-1508.73%-2.89

-1382.50%-3.54

-227.46%-0.69

14.04%-0.17

29.76%-0.18

11.06%-0.24

-546.80%-0.21

28.48%-0.20

-73.15%-0.26

3.87%-0.27

90.27%-0.03

-38.81%-0.28

42.79%-0.15

-23.12%-0.28

-107.92%-0.33

-38.57%-0.20

37.81%-0.26

-88.25%-0.23

---0.16

---0.15

---0.41

---0.12

Diluted earnings per share

68.79%-1.10

-900.46%-6.86

-1122.52%-2.13

-1508.73%-2.89

-1382.50%-3.54

-227.46%-0.69

14.04%-0.17

29.76%-0.18

11.06%-0.24

-546.80%-0.21

28.48%-0.20

-73.15%-0.26

3.87%-0.27

90.27%-0.03

-38.81%-0.28

42.79%-0.15

-23.12%-0.28

-107.92%-0.33

-38.57%-0.20

37.81%-0.26

-88.25%-0.23

---0.16

---0.15

---0.41

---0.12

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Lyell Immunopharma Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing LYEL stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Lyell Immunopharma Inc's revenue at year end?



Lyell Immunopharma Inc reported 36.00K in revenue for fiscal year 2025, up from 61.00K in the previous year.

How much revenue did Lyell Immunopharma Inc report in the most recent quarter?



Lyell Immunopharma Inc reported 2.00K in revenue for the most recent quarter, an increase of -71.43% year over year.

What was Lyell Immunopharma Inc's net income for the year?



Lyell Immunopharma Inc posted -274.45M in net income for fiscal year 2025.

How much net income did Lyell Immunopharma Inc post in the last quarter?



Lyell Immunopharma Inc reported -24.15M in net income for the latest quarter。

What was Lyell Immunopharma Inc's annual operating profit?



Lyell Immunopharma Inc's operating income was -201.63M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.